Submission of a registration application to the FDA, for approval of The NGAL Test™

BioPorto submission today

September 2015

Today, BioPorto has submitted a registration application to the FDA, for approval of The NGAL Test™. Alongside the application process, BioPorto has initiated the establishment of a business platform in the US.

For full description, please see below:

Submission of FDA application for The NGAL Test™